From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
-
* Corresponding author: Sylvain Meloche sylvain.meloche@umontreal.ca
Journal of Hematology & Oncology 2010, 3:8 doi:10.1186/1756-8722-3-8
Accesses
- Last 30 days: 216 accesses
- Last 365 days: 3203 accesses
- All time: 7097 accesses